Key result
Diabetes risk score screening identifies ~50% of screened females at very high risk for T2DM.
Cross-Sectional (n=142)
Type 2 diabetes mellitus (T2DM) is a common metabolic disorder and one of the leading causes of morbidity and mortality in both developed and developing countries. Early recognition and intervention will be helpful in reducing the personal and financial cost of the disease. We used the diabetic risk score (DRS) and fasting plasma glucose test (FPGT) for identification the risk of T2DM. A total of 142 female participants were randomly participated in the present study. These participants were identified as 39 (27.5%) high risk (Gr-III) and 71 (50%) very high risk (Gr-IV) for T2DM groups according to the DRS. In addition with 13 (9.2%) and 2 (1.4%) were newly diagnosed as having HT and T2DM. Both HT and T2DM participants were older than the normal participants. BMI and WC were not significantly different in the comparison of T2DM with Non-T2DM and HT with Non-HT patients. The DRS would be practical to use as tool for T2DM risk screening while FPGT was used to identify impaired fasting glucose and T2DM onset. Then, we recommended FPGT for the individuals with high and very high DRS groups.
No takes yet. Share an insight, caveat, or question.
Thavorasak et al. (2017) conducted a cross-sectional in Type 2 diabetes mellitus risk (n=142). Diabetic risk score (DRS) and fasting plasma glucose test (FPGT) was evaluated on High or very high risk for T2DM by DRS, and newly diagnosed T2DM and hypertension. Screening with the diabetic risk score and fasting plasma glucose test in 142 females identified 27.5% at high risk, 50% at very high risk, and 1.4% with newly diagnosed T2DM.
Synapse has enriched 5 related papers. Consider them for comparative context: